Global Kinetics raises more than $14 million to bring its Parkinson’s wearable to the US

News

Author: Geoffrey ChangPublished: 3 June 2015

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

News image

Australian health technology company Global Kinetics Corporation (GKC) has raised AUD$14.8 million to expand its Parkinson’s technology to the US after it was cleared by the Food and Drug Administration.

The company’s lead device, the Parkinson’s KinetiGraph, is worn on the patient’s wrist and records movement data – which can then be analysed remotely by clinicians – as well as reminding users when to take their medication.

Andrew Maxwell, managing director of GKC, said: “The first thing we set out to do was to improve the quality of life of people with Parkinson’s.”

The technology was previously available to approximately 50,000 people with Parkinson’s, but the move will increase that number to 1 million.

“We are delivering on our vision to make measurable change to Parkinson’s disease globally,” Maxwell added.

Go Back

Share this story

Comments


Related articles


Cognitia PD app lead

Resources & Tools

Mind games: can this new gaming app help Parkinson’s patients track symptoms?

New app tracks cognitive Parkinson’s symptoms

READ MORE

Interviews

“I came home, spoke to my wife, and we cried together”

Meet the man using poetry to express his feelings about Parkinson’s

READ MORE
Tom Isaacs tribute lead

Perspectives

Tributes paid to “inspirational” Tom Isaacs

Social media users around the world react to death of Tom Isaacs

READ MORE